Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
10/18/2007 | US20070244141 Compounds for the treatment of metabolic disorders |
10/18/2007 | US20070244139 Indole Derivatives or Benzimidazole Derivatives for Modulating IkB Kinase |
10/18/2007 | US20070244133 Thienopyrimidines and Thiazolopyrimidines for Use in Medicine |
10/18/2007 | US20070244123 Heterocycle-carboxamide derivatives as raf kinase inhibitors |
10/18/2007 | US20070244115 Amino-Halogen-Imidazopyridines as Proton Pump Inhibitors |
10/18/2007 | US20070244068 2',3'-O-methylenestyryl-5'-alpha-(carboxymethylenephosphono)-N6-ethylaminocarbonyl-adenosine phosphate; modified mononucleoside phosphate by attaching degradation-resistant substituent on terminal phosphate; increase rate & total amount of mucin secretion; epithelial tissue, platelet aggregation diseases |
10/18/2007 | US20070243268 Compositions for regulating intestinal disorders and methods of use thereof |
10/18/2007 | US20070243247 Dosage Form Containing The Active Ingredient Cholylsarcosine |
10/18/2007 | US20070243231 Use of Whey Permeate for the Treatment of Metabolic Syndrome |
10/18/2007 | US20070243226 Growth factor complex |
10/18/2007 | US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
10/18/2007 | US20070243144 External Preparation |
10/18/2007 | CA2648980A1 Antisense oligonucleotides against acetylcholinesterase for treating inflammatory diseases |
10/18/2007 | CA2648604A1 Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor |
10/18/2007 | CA2648324A1 2-methylene-1.alpha.,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
10/18/2007 | CA2647903A1 Methods for the production of functional protein from dna having a nonsense mutation and the treatment of disorders associated therewith |
10/17/2007 | EP1845108A2 Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
10/17/2007 | EP1845104A1 Par-2 agonist |
10/17/2007 | EP1845091A1 Process for producing muscarine receptor antagonist and intermediate therefor |
10/17/2007 | EP1845081A1 Amide compound |
10/17/2007 | EP1844792A1 Therapeutic agent for constipation |
10/17/2007 | EP1844773A1 Percutaneous absorption preparation |
10/17/2007 | EP1844770A1 Tablets containing ornithine hydrochloride |
10/17/2007 | EP1843791A1 Treatment of degenerative diseases with the x-linked inhibitor of apoptosis |
10/17/2007 | EP1843789A2 Compositions and methods for treating fibrotic disorders |
10/17/2007 | EP1843772A1 Intravenous formulations of pde-5 inhibitors |
10/17/2007 | EP1843769A1 Fast-disintegrating dosage forms of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene |
10/17/2007 | EP1592669B1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
10/17/2007 | EP1531684B1 Method for controlling hairballs |
10/17/2007 | EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone |
10/17/2007 | EP1412028B1 Tetrahydroindolone derivatives linked to arylpiperazines |
10/17/2007 | EP1315505B1 Pharmaceutical compositions for headache, migraine, nausea and emesis |
10/17/2007 | EP1284724A4 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
10/17/2007 | EP1141728B1 Kidney disease detection and treatment |
10/17/2007 | CN101056644A Oral composition containing difructose anhydride |
10/17/2007 | CN101054577A A siRNA and expression carrier capable of inhibiting Bax gene expression and application of the same used as virus hepatitis B treatment medicament |
10/17/2007 | CN101054547A Health protection food containing carapax amydae and many kinds of Chinese traditional medicine decoction pieces and preparation method thereof |
10/17/2007 | CN101054416A HAb18GC2 monoclonal antibody and its light and heavy chain variable area genes, coding polypeptide and use |
10/17/2007 | CN101054378A Entikawei potassium used for curing acute and chronic hepatic disease and preparation method thereof |
10/17/2007 | CN101054356A Sodium acetylcysteine for removing phlegm and curing hepatopathy and preparation method thereof |
10/17/2007 | CN101054344A Lipoxin A4 analogs |
10/17/2007 | CN101053655A Preparing method for traditional Chinese medicine coptidis rhizome stir-fried with ginger juice |
10/17/2007 | CN101053642A Traditional Chinese medicinal composition for treating fatty liver and its preparation method |
10/17/2007 | CN101053631A Preparation method for effective drug capsule for gastric disease |
10/17/2007 | CN101053625A Medicinal composition and preparation for treating irritable bowel syndrome and preparation method thereof |
10/17/2007 | CN101053603A Fupo cold granules and preparation method thereof |
10/17/2007 | CN101053602A Medicine for treating oral ulcer and its preparing method |
10/17/2007 | CN101053595A Medicinal preparation for treating constipation and its preparing method |
10/17/2007 | CN101053594A Traditional Chinese medicinal composition for treating lithiasis and its preparation method |
10/17/2007 | CN101053589A Method for extracting active constituent from Tibetan capillary |
10/17/2007 | CN101053585A Preparation method and application for phyllanthus oral solid preparations |
10/17/2007 | CN101053584A Medicinal composition for treating chronic hepatitis and its preparation |
10/17/2007 | CN101053579A Application of brucea fruit oil nanometer emulsion in preparing gastrointestinal mucosa protective agent |
10/17/2007 | CN101053571A Gentiopicroside drop pill and preparation method thereof |
10/17/2007 | CN101053569A Bismuth glycyrrhizate capsule and its preparation |
10/17/2007 | CN101053562A Otilonium bromide capsule |
10/17/2007 | CN101053556A Water soluble coenzyme Q10 hydroxyl-beta-cyclodextrin inclusion compound and its preparation method |
10/17/2007 | CN101053437A Organic germanium Ge-132 glossy ganoderma beverage and processing method |
10/17/2007 | CN101053432A Spleen-invigorating beverage for children |
10/17/2007 | CN101053431A Orange jujube antidiarrheal beverage |
10/17/2007 | CN101053421A Radish abalone soup |
10/17/2007 | CN101053418A Magnolia snakehead soup |
10/17/2007 | CN101053412A Pork liver blood-enriching soup |
10/17/2007 | CN101053411A Medlar shredded pork |
10/17/2007 | CN101053407A Jujube medlar tea and producing technology thereof |
10/17/2007 | CN101053399A Matrimony vine cucumberskin |
10/17/2007 | CN101053386A 糯米保健粥 Glutinous rice porridge health |
10/17/2007 | CN101053375A Eggs with non-pollution and building up body functions |
10/17/2007 | CN101053362A Rhodiola chewing gum and its preparation method |
10/17/2007 | CN100343266C Picrorhiza total glycoside extract and its application in preparation of liver disease medicine and preparation method |
10/17/2007 | CN100343258C Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
10/17/2007 | CN100343256C Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists |
10/17/2007 | CN100343252C Novel imidazopyridine compounds with therapeutic effect |
10/17/2007 | CN100343251C Substituted homopiperidinyl benzimidazole analogues as fundic relaxants |
10/17/2007 | CN100342915C Stem cell target-locating and enriching method |
10/17/2007 | CN100342909C Thymosin alpha-1 aqua prepn and its prepn process and application |
10/17/2007 | CN100342903C Chinese medicine composition for treating gastrointestinal diseases |
10/17/2007 | CN100342893C Medicine, food used article for preventing and curing acute diarrhoea and method for producing the same |
10/17/2007 | CN100342892C Medicine, food used article for preventing and curing diarrhoea and method for producing the same |
10/17/2007 | CN100342881C Natural Yin-nourishing and Yang-strengthening health food capsule and its prepn process |
10/17/2007 | CN100342880C Oral liquid of royal jelly of ginseng and hairy antler, and preparation method |
10/17/2007 | CN100342876C Enema mixture for treating ileus and method for preparing same |
10/17/2007 | CN100342874C Chinese medicine powder for treating viral hepatitis B and its preparation |
10/17/2007 | CN100342867C Kidney-nourishing yang-strengthening medicine |
10/17/2007 | CN100342860C Actacid composition |
10/17/2007 | CN100342849C Effervescence tablet for relieving cough and asthma and its preparation process |
10/17/2007 | CN100342796C Food product and process for manufacturing same |
10/16/2007 | US7282591 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
10/16/2007 | US7282516 CB1, cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
10/16/2007 | US7282508 Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
10/16/2007 | US7282504 Kinase inhibitors |
10/16/2007 | US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide |
10/16/2007 | US7282500 Nitrogen compounds such as 4-(1-Hydroxyimino-indan-5-yl)-5-pyridin-4-yl-1H-imidazole-2-carboxylic Acid (2-morpholin-4-yl-ethyl)-amide, used as anticarcinogenic agents and for prophylaxis of brain disorders |
10/16/2007 | US7282496 Rheumatic diseases; bone disorders; Aids; antiinflammatory agents |
10/16/2007 | US7282490 Osteopontin-related compositions and methods |
10/16/2007 | US7282368 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome |
10/16/2007 | US7282344 Also mutated GABAA receptor subunits, polynucleotide sequences encoding mutated subunits, expression vectors comprising the mutated subunits, host cells capable of expressing the mutated subunits, drug screening methods, and chemical substances identified by the method; high throughput drug screening |
10/16/2007 | US7282206 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
10/16/2007 | US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders |
10/16/2007 | CA2414018C 2-aminocarbonyl-9h-purine derivatives |